Literature DB >> 16076294

Allergy and cancer.

B Lindelöf1, F Granath, M Tengvall-Linder, A Ekbom.   

Abstract

BACKGROUND: Conflicting results have provided support for two distinct and contradictory hypotheses: (i) allergy has a protective effect against cancer by enhanced immune surveillance, and (ii) allergy is associated with an increased risk of cancer by chronic immune stimulation. We therefore aimed us to perform a large epidemiological study with a defined allergic disease cohort.
METHODS: During the years 1988-2000, 70 136 patients tested for total serum immunoglobulin E (IgE) and 57 815 tested with Phadiatop for diagnosing allergic disease at Karolinska University Hospital, Stockholm, Sweden, were linked with the Swedish Cancer Registry for a virtually complete follow up with regard to cancer.
FINDINGS: The total number of observed cancers was normal in the total serum IgE-cohort; standardized incidence ratio (SIR) = 0.98 (95% CI: 0.92-1.04) and in the Phadiatop-cohort: SIR = 0.99 (0.92-1.06) independent of the level of IgE and positive or negative Phadiatop. Specific analysis was done for cancer of the lung, cervix, pancreas, lymphoma, and nonmelanoma skin cancer. None of these forms of cancer had increased risks.
INTERPRETATION: The study does not support the hypothesis that allergy has a protective effect against cancer, nor does it support an increased risk.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16076294     DOI: 10.1111/j.1398-9995.2005.00808.x

Source DB:  PubMed          Journal:  Allergy        ISSN: 0105-4538            Impact factor:   13.146


  19 in total

1.  Allergies and adult gliomas: cohort results strengthen evidence for a causal association.

Authors:  Faith G Davis; Umaima Al-Alem
Journal:  J Natl Cancer Inst       Date:  2011-10-18       Impact factor: 13.506

2.  Atopic allergic conditions and pancreatic cancer risk: Results from the Multiethnic Cohort Study.

Authors:  Brian Z Huang; Loic Le Marchand; Christopher A Haiman; Kristine R Monroe; Lynne R Wilkens; Zuo-Feng Zhang; Veronica Wendy Setiawan
Journal:  Int J Cancer       Date:  2018-01-12       Impact factor: 7.396

Review 3.  AllergoOncology: the role of IgE-mediated allergy in cancer.

Authors:  E Jensen-Jarolim; G Achatz; M C Turner; S Karagiannis; F Legrand; M Capron; M L Penichet; J A Rodríguez; A G Siccardi; L Vangelista; A B Riemer; H Gould
Journal:  Allergy       Date:  2008-07-26       Impact factor: 13.146

4.  Prediagnostic immunoglobulin E levels and risk of chronic lymphocytic leukemia, other lymphomas and multiple myeloma-results of the European Prospective Investigation into Cancer and Nutrition.

Authors:  Alexandra Nieters; Anna Łuczyńska; Susen Becker; Nikolaus Becker; Roel Vermeulen; Kim Overvad; Krasimira Aleksandrova; Heiner Boeing; Pagona Lagiou; Dimitrios Trichopoulos; Antonia Trichopoulou; Vittorio Krogh; Giovanna Masala; Salvatore Panico; Rosario Tumino; Carlotta Sacerdote; Bas Bueno-de-Mesquita; Suzanne M Jeurnink; Elisabete Weiderpass; Eva Ardanaz; Maria-Dolores Chirlaque; María-José Sánchez; Soledad Sánchez; Signe Borgquist; Salma Butt; Beatrice Melin; Florentin Späth; Sabina Rinaldi; Paul Brennan; Rachel S Kelly; Elio Riboli; Paolo Vineis; Rudolf Kaaks
Journal:  Carcinogenesis       Date:  2014-09-30       Impact factor: 4.944

5.  Risk of squamous cell carcinoma of the skin in relation to IgE: a nested case-control study.

Authors:  Joseph L Wiemels; John K Wiencke; Zhongze Li; Christian Ramos; Heather H Nelson; Margaret R Karagas
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-09-23       Impact factor: 4.254

Review 6.  The History of IgE: From discovery to 2010.

Authors:  S G O Johansson
Journal:  Curr Allergy Asthma Rep       Date:  2011-04       Impact factor: 4.806

7.  Serum immunoglobulin e and risk of pancreatic cancer in the prostate, lung, colorectal, and ovarian cancer screening trial.

Authors:  Sara H Olson; Meier Hsu; Joseph L Wiemels; Paige M Bracci; Mi Zhou; Joseph Patoka; William R Reisacher; Julie Wang; Robert C Kurtz; Debra T Silverman; Rachael Z Stolzenberg-Solomon
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-04-09       Impact factor: 4.254

8.  Allergies and risk of pancreatic cancer: a pooled analysis from the Pancreatic Cancer Case-Control Consortium.

Authors:  Sara H Olson; Meier Hsu; Jaya M Satagopan; Patrick Maisonneuve; Debra T Silverman; Ersilia Lucenteforte; Kristin E Anderson; Ayelet Borgida; Paige M Bracci; H Bas Bueno-de-Mesquita; Michelle Cotterchio; Qi Dai; Eric J Duell; Elizabeth H Fontham; Steven Gallinger; Elizabeth A Holly; Bu-Tian Ji; Robert C Kurtz; Carlo La Vecchia; Albert B Lowenfels; Brian Luckett; Emmy Ludwig; Gloria M Petersen; Jerry Polesel; Daniela Seminara; Lori Strayer; Renato Talamini
Journal:  Am J Epidemiol       Date:  2013-07-02       Impact factor: 4.897

9.  Atopic disease and risk of non-Hodgkin lymphoma: an InterLymph pooled analysis.

Authors:  Claire M Vajdic; Michael O Falster; Silvia de Sanjose; Otoniel Martínez-Maza; Nikolaus Becker; Paige M Bracci; Mads Melbye; Karin Ekström Smedby; Eric A Engels; Jennifer Turner; Paolo Vineis; Adele Seniori Costantini; Elizabeth A Holly; Eleanor Kane; John J Spinelli; Carlo La Vecchia; Tongzhang Zheng; Brian C-H Chiu; Luigino Dal Maso; Pierluigi Cocco; Marc Maynadié; Lenka Foretova; Anthony Staines; Paul Brennan; Scott Davis; Richard Severson; James R Cerhan; Elizabeth C Breen; Brenda Birmann; Wendy Cozen; Andrew E Grulich
Journal:  Cancer Res       Date:  2009-08-04       Impact factor: 12.701

Review 10.  Epidemiology of pancreatic cancer and the role of family history.

Authors:  Sara H Olson; Robert C Kurtz
Journal:  J Surg Oncol       Date:  2012-05-15       Impact factor: 3.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.